Page 3 - Nasdaq Blu News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Nasdaq blu. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Nasdaq Blu Today - Breaking & Trending Today

BELLUS Health (NASDAQ:BLU) Sees Strong Trading Volume

BELLUS Health Inc. (NASDAQ:BLU – Get Rating) shares saw strong trading volume on Wednesday . 323,183 shares were traded during mid-day trading, a decline of 51% from the previous session’s volume of 664,591 shares.The stock last traded at $6.90 and had previously closed at $6.95. Analyst Upgrades and Downgrades A number of equities analysts recently […] ....

Perceptive Advisors , Health Company Profile , Bellus Health Inc , Health Daily , Health Stock , Royal Bank , Goldman Sachs Group Inc , Health Inc , Get Rating , Sachs Group , Asset Management , Bellus Health , Nasdaq Blu ,

BELLUS Health (NASDAQ:BLU) Shares Up 6.3%

Shares of BELLUS Health Inc. (NASDAQ:BLU – Get Rating) shot up 6.3% on Thursday . The company traded as high as $6.89 and last traded at $6.87. 387,856 shares changed hands during trading, a decline of 41% from the average session volume of 662,235 shares. The stock had previously closed at $6.46. Analyst Upgrades and […] ....

Health Company Profile , Royal Bank , Health Trading , Manufacturers Life Insurance Company , Health Inc , Health Daily , Chartwell Investment Partners , Get Rating , Investment Partners , Capital Management , Global Management , Commodore Capital , Bellus Health , Nasdaq Blu ,

BELLUS Health's (BLU) Buy Rating Reaffirmed at HC Wainwright

HC Wainwright reiterated their buy rating on shares of BELLUS Health (NASDAQ:BLU – Get Rating) in a research report sent to investors on Wednesday, Benzinga reports. They currently have a $20.00 target price on the stock. HC Wainwright also issued estimates for BELLUS Health’s Q1 2023 earnings at ($0.20) EPS, Q2 2023 earnings at ($0.21) […] ....

Health Stock Performance , Health Daily , Goldman Sachs Group Inc , Perceptive Advisors , Health Inc , Get Rating , Sachs Group , Asset Management , Bellus Health , Nasdaq Blu , Reiterated Rating , Hc Wainwright ,

FY2027 EPS Estimates for BELLUS Health Inc. Lifted by Analyst (NASDAQ:BLU)

BELLUS Health Inc. (NASDAQ:BLU – Get Rating) – Analysts at Jefferies Financial Group upped their FY2027 EPS estimates for BELLUS Health in a research report issued to clients and investors on Tuesday, March 21st. Jefferies Financial Group analyst S. Jeong now anticipates that the company will post earnings per share of $4.17 for the year, […] ....

Nova Scotia , Health Inc , First Light Asset Management , Cibc World Market Inc , Bellus Health Inc , Jefferies Financial Group , Analysts At Jefferies Financial Group , Health Stock Performance , Blackrock Inc , Health Daily , Jpmorgan Chase Co , Royal Bank , Affinity Asset Advisors , Get Rating , Financial Group , World Market , Asset Advisors , Light Asset Management , Bellus Health , Nasdaq Blu , Earnings Estimates , Jefferies Financial Group Inc ,

BELLUS Health's (BLU) Buy Rating Reiterated at HC Wainwright

HC Wainwright reissued their buy rating on shares of BELLUS Health (NASDAQ:BLU – Get Rating) in a research note published on Wednesday, Benzinga reports. They currently have a $20.00 target price on the stock. HC Wainwright also issued estimates for BELLUS Health’s Q1 2023 earnings at ($0.20) EPS, Q2 2023 earnings at ($0.21) EPS, Q3 […] ....

Health Inc , Tower Research Capital , Toronto Dominion Bank , Great West Life Assurance Co , Health Daily , Health Trading Down , Deutsche Bank , Group Plc , Get Rating , Trading Down , West Life Assurance , Dominion Bank , General Group Plc , Research Capital , Bellus Health , Nasdaq Blu , Reiterated Rating , Hc Wainwright ,